Evidence map›Paper›PMID 32193740›Full record

ArticleObesity surgery2020

Erosive Esophagitis and Symptoms of Gastroesophageal Reflux Disease in Patients with Morbid Obesity with and without Type 2 Diabetes: a Cross-sectional Study.

Jolanta Lorentzen, Asle W Medhus, Jens Kristoffer Hertel, Heidi Borgeraas, Tor-Ivar Karlsen, Ronette L Kolotkin, Rune Sandbu, Daniel Sifrim, Marius Svanevik, Dag Hofsø and 2 more

Registry-linked trialOpen access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Obesity surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01778738 (Glycaemia, Insulin Secretion and Action in Morbidly Obese Subjects With Type 2 Diabetes After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01778738 nacompletednot on this map

Glycaemia, Insulin Secretion and Action in Morbidly Obese Subjects With Type 2 Diabetes After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass: A Randomised Single Centre Study

TypeinterventionalSponsorSykehuset i Vestfold HFRan2013 to 2022Enrolled125ConditionsType 2 Diabetes, Morbid ObesityArmsBariatric surgery, either gastric bypass surgery or sleeve gastrectomy, Sleeve gastrecomy, Bastric bypass
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Jolanta LorentzenMorbid Obesity Center, Vestfold Hospital Trust, Tønsberg, Norway. jolanta.lorentzen@siv.no.
Asle W MedhusDepartment of Gastroenterology, Oslo University Hospital, Ullevål, Oslo, Norway.
Jens Kristoffer HertelMorbid Obesity Center, Vestfold Hospital Trust, Tønsberg, Norway.
Heidi BorgeraasMorbid Obesity Center, Vestfold Hospital Trust, Tønsberg, Norway.
Tor-Ivar KarlsenMorbid Obesity Center, Vestfold Hospital Trust, Tønsberg, Norway.
Ronette L KolotkinMorbid Obesity Center, Vestfold Hospital Trust, Tønsberg, Norway.
Rune SandbuMorbid Obesity Center, Vestfold Hospital Trust, Tønsberg, Norway.
Daniel SifrimBarts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Marius SvanevikDepartment of Gastrointestinal Surgery, Vestfold Hospital Trust, Tønsberg, Norway.
Dag HofsøMorbid Obesity Center, Vestfold Hospital Trust, Tønsberg, Norway.
Birgitte SeipDepartment of Medicine, Vestfold Hospital Trust, Tønsberg, Norway.
Jøran HjelmesæthMorbid Obesity Center, Vestfold Hospital Trust, Tønsberg, Norway.
Sykehuset i Vestfold · NOUniversity of Oslo · NOOslo University Hospital · NOQueen Mary University of London · GBUniversity of Agder · NO

Funding

Universitetet i Oslo PhD grant
6 · The paper itself

Abstract

backgroundType 2 diabetes (T2DM) is associated with gastroesophageal reflux disease (GERD) in the general population, but the relationship between these conditions in candidates for bariatric surgery is uncertain. We compared the prevalence of GERD and the association between GERD symptoms and esophagitis among bariatric candidates with and without T2DM.

methodsCross-sectional study of baseline data from the Oseberg study in Norway. Both groups underwent gastroduodenoscopy and completed validated questionnaires: Gastrointestinal Symptom Rating Scale and Gastroesophageal Reflux Disease Questionnaire. Participants with T2DM underwent 24-h pH-metry.

resultsA total of 124 patients with T2DM, 81 women, mean (SD) age 48.6 (9.4) years and BMI 42.3 (5.5) kg/m

conclusionsThe prevalence of GERD was similar in bariatric patients with or without T2DM, and the proportion of patients with asymptomatic GERD was high independent of the presence or absence of T2DM. Accordingly, GERD may be underdiagnosed in patients not undergoing a preoperative endoscopy or acid reflux assessment.

trial registrationClinical Trials.gov number NCT01778738.

Indexed as

Diabetes Mellitus, Type 2Gastroesophageal RefluxObesity, MorbidAdultCross-Sectional StudiesFemaleHumansMiddle AgedNorwayAcid refluxAcid regurgitationBariatric surgeryErosive esophagitisGastroesophageal reflux disease (GERD)HeartburnObesityType 2 diabetes mellitus

Identifiers

PMID32193740
OpenAlexW3011555474

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.